🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,742 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10716856

Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

The Board of Regents of the University of Texas System · Granted Tue Jul 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10703721

Caffeic acid derivatives and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10703805

Molecular imprinting of West Nile antibodies with physiological pH matching

The Board of Regents of the University of Texas System · Granted Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10703698

Compounds which activate estrogen receptors and compositions and methods of using the same

The Board of Regents of the University of Texas System · Granted Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10696710

Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

The Board of Regents of the University of Texas System · Granted Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10687520

Generation and correction of a humanized mouse model with a deletion of dystrophin exon 44

The Board of Regents of the University of Texas System · Granted Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10688203

Methods of performing brachytherapy

The Board of Regents of the University of Texas System · Granted Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10682339

Pharmaceutical compositions directly targeting FKBP52 for the treatment of prostate cancer

The Board of Regents of the University of Texas System · Granted Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10682388

Targeting of PELP1 in cancer therapy

The Board of Regents of the University of Texas System · Granted Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10683366

Methods and compositions for treatment of atherosclerosis

The Board of Regents of the University of Texas System · Granted Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10669516

Methods and apparatus for conditioning cell populations for cell therapies

The Board of Regents of the University of Texas System · Granted Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10668085

Thermo-kinetic mixing for pharmaceutical applications

The Board of Regents of the University of Texas System · Granted Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10660850

Compositions and methods of making brittle-matrix particles through blister pack freezing

The Board of Regents of the University of Texas System · Granted Tue May 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10661095

Photodynamic therapy for use in treating cancer

The Board of Regents of the University of Texas System · Granted Tue May 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10653150

Shelf life and color profile of resin compositions with silver nanoparticles

The Board of Regents of the University of Texas System · Granted Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10646438

Methods for inducing an immune response via buccal and/or sublingual administration of a v

The Board of Regents of the University of Texas System · Granted Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10646574

Formulations of intraarticular pharmaceutical agents and methods for preparing and using t

The Board of Regents of the University of Texas System · Granted Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10639277

Multi-functional echogenic immunoliposomes for directed stem cell delivery to atheroma

The Board of Regents of the University of Texas System · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10633657

Methods for treatment of polycystic kidney disease

The Board of Regents of the University of Texas System · Granted Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10633445

T-cell receptor (TCR)-binding antibodies and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10633411

Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

The Board of Regents of the University of Texas System · Granted Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10633442

Antibodies to connexin 43 (Cx43) hemichannels and methods of use thereof to inhibit Cx43 h

The Board of Regents of the University of Texas System · Granted Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10633363

EPAC1 activators as HIV latency reversal agents (LRA)

The Board of Regents of the University of Texas System · Granted Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10626087

Indoline and tetrahydroquinoline sulfonyl inhibitors of dimetalloenzymes and use of the sa

The Board of Regents of the University of Texas System · Granted Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted